Faster Time-to-Therapeutic Tacrolimus Level is Associated with Lower Risk of Cellular Rejection Early after Heart Transplantation
Faster time-to-therapeutic tacrolimus (TTT) levels is associated with lower rates of acute cellular rejection (ACR) in kidney and liver transplantation. Limited data have evaluated this relationship in heart transplant (HT) recipients.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: D.L. Jennings, D. Salerno, N. Lange, K.J. Clerkin, K. Axsom, E.F. Lin, S.W. Restaino, F. Latif, V.K. Topkara, M. Yuzefpolskaya, K. Takeda, P. Colombo, M. Farr Tags: (1292) Source Type: research
More News: Cardiology | Heart | Heart Transplant | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Lung Transplant | Prograf | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology